Skip to main content
WeightCited

Glutamine için Obesity

C Kanıt Küçük çalışmalardan sınırlı kanıt mevcuttur, ancak bazı olumlu sinyaller bulunmaktadır.

RCT (n=66) found 30 g/day reduced weight and waist circumference comparably to isonitrogenous protein control. Systematic review of 7 trials found improved inflammatory markers and gut barrier function in obese patients. Evidence is preliminary but growing, with benefits potentially mediated through the gut-metabolic axis.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'ingredient\u003Dglutamine\u0026condition\u003Dobesity'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

Sonuç

RCT (n=66) found 30 g/day reduced weight and waist circumference comparably to isonitrogenous protein control. Systematic review of 7 trials found improved inflammatory markers and gut barrier function in obese patients. Evidence is preliminary but growing, with benefits potentially mediated through the gut-metabolic axis.

Key Study Findings

Other
[Nutrition in the prevention and healing of chronic wounds. Importance in improving the diabetic foot].
Dose: None vs: None Outcome: None Etki: None None

Popülasyon: chronic wounds and have been linked to delayed wound healing and dehiscence

Review
Role of L-Arginine in Nitric Oxide Synthesis and Health in Humans.
Dose: None vs: None Outcome: None Etki: None None

Popülasyon: Humans (general)

Review
The Na+/Cl--Coupled, Broad-Specific, Amino Acid Transporter SLC6A14 (ATB0,+): Emerging Roles in Multiple Diseases and Therapeutic …
Dose: None vs: None Outcome: None Etki: None None

Popülasyon: Cancer patients (SLC6A14 transporter review)

Key Statistics

7

Çalışmalar

300

Katılımcılar

Positive

C

Derece

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Yaygın Kullanılan Dozajlar

general:
5-10 g/day
guthealth:
10-20 g/day
exerciserecovery:
5-10 g pre/post workout

Üst sınır: 40 g/day (well-tolerated in clinical trials)

Araştırmalarda İncelenen Dozajlar

Dozaj Süre Etki N
None -- Positive --
None -- Mixed --
None -- Mixed --

En iyi alım zamanı: Between meals or pre/post-exercise; may add to protein shakes

Safety & Side Effects

Bildirilen Yan Etkiler

  • Bloating
  • GI discomfort
  • Constipation

Bilinen Etkileşimler

  • Lactulose (may reduce effectiveness)
  • Anticonvulsants (may reduce effectiveness)

Tolere edilebilir üst alım: 40 g/day (well-tolerated in clinical trials)

Herhangi bir takviye kullanmaya başlamadan önce mutlaka sağlık uzmanınıza danışın.Herhangi bir takviye başlatmadan önce her zaman sağlık uzmanınıza danışın.

Frequently Asked Questions

Does Glutamine help with Obesity?
Based on 7 studies with 300 participants, there is limited but promising evidence that Glutamine may support Obesity management. Our evidence grade is C (Some Evidence).
How much Glutamine should I take for Obesity?
Studies have used various dosages. A commonly studied range is 5-10 g/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Glutamine?
Reported side effects may include Bloating, GI discomfort, Constipation. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Glutamine and Obesity?
We rate the evidence as Grade C (Some Evidence). This rating is based on 7 peer-reviewed studies with 300 total participants. The overall direction of effect is positive.

References

  1. [1] Guoyao Wu et al.. Adv Exp Med Biol. 2021. Role of L-Arginine in Nitric Oxide Synthesis and Health in Humans. doi:10.1007/978-3-030-74180-8_10 PubMed
  2. [2] Rosa María Martínez García et al.. Nutr Hosp. 2021. [Nutrition in the prevention and healing of chronic wounds. Importance in improving the diabetic foot]. doi:10.20960/nh.03800 PubMed
  3. [3] Mohd Omar F Sikder et al.. AAPS J. 2017. The Na+/Cl--Coupled, Broad-Specific, Amino Acid Transporter SLC6A14 (ATB0,+): Emerging Roles in Multiple Diseases and Therapeutic Potential for Treatment and Diagnosis. doi:10.1208/s12248-017-0164-7 PubMed

FDA Sorumluluk Reddi: Bu ifadeler Gıda ve İlaç Dairesi (FDA) tarafından değerlendirilmemiştir. Bu web sitesindeki ürünler ve bilgiler herhangi bir hastalığı teşhis etmek, tedavi etmek, iyileştirmek veya önlemek amacıyla tasarlanmamıştır. Sunulan kanıt dereceleri, yayımlanmış hakemli araştırmalarımızın analizine dayanmaktadır ve tıbbi tavsiye niteliği taşımamaktadır. Herhangi bir takviye rejimine başlamadan önce her zaman sağlık uzmanınıza danışın.